m.LearnBecome a PartnerBecome a Partner
m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
Venmax Drugs & Pharmaceuticals Ltd logo

Venmax Drugs & Pharmaceuticals Ltd Share Price

Current price unavailable.
As on - | -
PharmaceuticalsSmall Cap
BuySell

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 --
R2--
R3--
PP- -
S1--
S2--
S3 --

Ratios

ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
ROCE-3.110.3-0.367.09
ROE-4.020.36-0.2451.69
EPS0.050.050.071.49-0.95

Peer Comparison

No data available
Scrip NamePriceDaily changeM CapPE Ratio1 Year Return

Corporate Action

April 14, 2026
Submission of Annual Secretarial Compliance Report for the year ended March 31 2026.
April 14, 2026
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026.
April 14, 2026
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyVenmax Drugs and Pharmaceuticals Ltd
2CIN NO.L24230TG1988PLC009102
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY 0
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Priyanka Agarwal
Designation: Company Secretary and Compliance Officer
EmailId: venmaxdrugs@gmail.com
Name of the Chief Financial Officer: Kummarikuntla Saibaba
Designation: Chief Financial Officer
EmailId: venmaxdrugs@gmail.com

Date: 14/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

About Venmax Drugs & Pharmaceuticals Ltd

Equity img
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its na...
ISIN :INE154G01022

Registered Office

Sy No 115 Brig Sayeed Road,Hanumanji Colony Old Bowenpall

Contact number

-

Email

Registrars

CIL Securities Limited
214 RaghavaRatna Tow Chiragali Lane Abids Hyderabad 500001

Contact number

+ 91-040-23202465/2320

Email

Management

- (Chairman)

Open IPO’s

View All

FAQs

The share price of Venmax Drugs & Pharmaceuticals Ltd on the BSE is - as on -

Note : Securities shown above are only for illustrative purposes and not recommendatory in nature. The data represents best/cumulative figures till date.